Company page
Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A
Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A, trading under the ticker 688266, is a public company based in China. The company has a market capitalization of approximately 3.51 billion USD. Zelgen focuses on the development and commercialization of innovative biopharmaceutical products.
- Ticker
- 688266:SSE
- Asset type
- Stock
- Market cap
- $3.51B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SSE
- Currency
- CNY